Results 151 to 160 of about 833,621 (293)
Ruxolitinib is a JAK-1/JAK-2 inhibitor indicated for the treatment of polycythemia vera and primary or secondary myelofibrosis. Only one patient (0.2%) was diagnosed with tuberculosis among the 485 patients receiving ruxolitinib in the four pivotal ...
Sylvain Lescuyer+9 more
doaj
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues
C. Meehan+40 more
semanticscholar +1 more source
Chemical and immunological properties of polysaccharides of wax D extracted from Mycobacterium tuberculosis strain Aoyama B [PDF]
Ichiro Azuma+2 more
openalex +1 more source
Thermal Death Time Curve of Mycobacterium tuberculosis var. bovis in Artificially Infected Milk1 [PDF]
H. R. Kells, S. A. Lear
openalex +2 more sources
Mycobacterium Battey infection resembling tuberculosis. [PDF]
Barry R. Adels, P. J. Cox
openalex +1 more source
Mycobacterium tuberculosis, the etiologic agent of Tuberculosis, is a pathogen that is widely distributed geographically. Tuberculosis is classified as a granulomatous inflammatory condition where effector cells accumulate at the site of mycobacterial ...
Gerardo Fernando Fernández Soto+5 more
doaj
Isolation and structure of mycobactin T, a growth factor from Mycobacterium tuberculosis [PDF]
GA Snow
openalex +1 more source
Studies on<sub>a</sub><sup>-</sup>Chemotherapeutics for <i>Mycobacterium tuberculosis</i>. I
Hyozo Taniyama+3 more
openalex +2 more sources